Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3186198 | 0.89 | ESR1 (0.36) | EGLN1ESR1ESR2NPSR1POLB | |
| SCHEMBL3199631 | 0.85 | EGLN1 (0.36) | EGLN1ESR1ESR2NPSR1ADAMTS5 | |
| SCHEMBL3176253 | 0.84 | TP53 (0.34) | EGLN1ESR1ESR2NPSR1ADAMTS5 | |
| SCHEMBL10037546 | 0.80 | ALDH1A1 (0.33) | EGLN1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL10037385 | 0.80 | KDM4E (0.35) | EGLN1NPSR1POLBALDH1A1CYP1A2 | |
| SCHEMBL3076018 | 0.75 | ALDH1A1 (0.38) | EGLN1NPSR1ADAMTS5ALDH1A1CYP1A2 | |
| SCHEMBL20202064 | 0.74 | ALDH1A1 (0.44) | EGLN1NPSR1ADAMTS5ALDH1A1CYP1A2 | |
| SCHEMBL21345488 | 0.74 | ADAMTS5 (0.38) | EGLN1ESR1NPSR1ADAMTS5ALDH1A1 | |
| SCHEMBL3209570 | 0.70 | NPC1 (0.32) | EGLN1ADAMTS5 | |
| SCHEMBL20202034 | 0.70 | ALDH1A1 (0.39) | EGLN1NPSR1POLBADAMTS5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120001537-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001537-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | OR10J3, ORC3, PIEZO1 | EGLN1 1527/4885ESR1 34/4885ESR2 229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.